{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:14:48Z","timestamp":1791213288353,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T00:00:00Z","timestamp":1524787200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T00:00:00Z","timestamp":1524787200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS38377"],"award-info":[{"award-number":["NS38377"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS082205"],"award-info":[{"award-number":["NS082205"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R21NS098006"],"award-info":[{"award-number":["R21NS098006"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012443","name":"Maryland Stem Cell Research Fund","doi-asserted-by":"publisher","award":["2012-MSCRFE-0059"],"award-info":[{"award-number":["2012-MSCRFE-0059"]}],"id":[{"id":"10.13039\/100012443","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s40478-018-0538-9","type":"journal-article","created":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T08:07:05Z","timestamp":1524816425000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["D409H GBA1 mutation accelerates the progression of pathology in A53T \u03b1-synuclein transgenic mouse model"],"prefix":"10.1186","volume":"6","author":[{"given":"Donghoon","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heehong","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seulah","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Ho","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Hong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SangMin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0864-5239","authenticated-orcid":false,"given":"Han Seok","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,27]]},"reference":[{"key":"538_CR1","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1093\/brain\/awv179","volume":"138","author":"RN Alcalay","year":"2015","unstructured":"Alcalay RN, Levy OA, Waters CC, Fahn S, Ford B, Kuo SH, Mazzoni P, Pauciulo MW, Nichols WC, Gan-Or Z et al (2015) Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations. Brain 138:2648\u20132658. \n                    https:\/\/doi.org\/10.1093\/brain\/awv179","journal-title":"Brain"},{"key":"538_CR2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13024-015-0010-2","volume":"10","author":"D Chiasserini","year":"2015","unstructured":"Chiasserini D, Paciotti S, Eusebi P, Persichetti E, Tasegian A, Kurzawa-Akanbi M, Chinnery PF, Morris CM, Calabresi P, Parnetti L et al (2015) Selective loss of glucocerebrosidase activity in sporadic Parkinson's disease and dementia with Lewy bodies. Mol Neurodegener 10:15. \n                    https:\/\/doi.org\/10.1186\/s13024-015-0010-2","journal-title":"Mol Neurodegener"},{"key":"538_CR3","doi-asserted-by":"publisher","first-page":"e0143854","DOI":"10.1371\/journal.pone.0143854","volume":"10","author":"S Choi","year":"2015","unstructured":"Choi S, Kim D, Kam TI, Yun S, Kim S, Park H, Hwang H, Pletnikova O, Troncoso JC, Dawson VL et al (2015) Lysosomal enzyme Glucocerebrosidase protects against Abeta1-42 oligomer-induced neurotoxicity. PLoS One 10:e0143854. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0143854","journal-title":"PLoS One"},{"key":"538_CR4","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1001\/archneurol.2009.54","volume":"66","author":"LN Clark","year":"2009","unstructured":"Clark LN, Kartsaklis LA, Wolf Gilbert R, Dorado B, Ross BM, Kisselev S, Verbitsky M, Mejia-Santana H, Cote LJ, Andrews H et al (2009) Association of glucocerebrosidase mutations with dementia with lewy bodies. Arch Neurol 66:578\u2013583. \n                    https:\/\/doi.org\/10.1001\/archneurol.2009.54","journal-title":"Arch Neurol"},{"key":"538_CR5","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.1523\/JNEUROSCI.5367-11.2012","volume":"32","author":"E Colla","year":"2012","unstructured":"Colla E, Coune P, Liu Y, Pletnikova O, Troncoso JC, Iwatsubo T, Schneider BL, Lee MK (2012) Endoplasmic reticulum stress is important for the manifestations of alpha-synucleinopathy in vivo. J Neurosci 32:3306\u20133320. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.5367-11.2012","journal-title":"J Neurosci"},{"key":"538_CR6","doi-asserted-by":"publisher","first-page":"3301","DOI":"10.1523\/JNEUROSCI.5368-11.2012","volume":"32","author":"E Colla","year":"2012","unstructured":"Colla E, Jensen PH, Pletnikova O, Troncoso JC, Glabe C, Lee MK (2012) Accumulation of toxic alpha-synuclein oligomer within endoplasmic reticulum occurs in alpha-synucleinopathy in vivo. J Neurosci 32:3301\u20133305. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.5368-11.2012","journal-title":"J Neurosci"},{"key":"538_CR7","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1093\/hmg\/dds057","volume":"21","author":"JP Daher","year":"2012","unstructured":"Daher JP, Pletnikova O, Biskup S, Musso A, Gellhaar S, Galter D, Troncoso JC, Lee MK, Dawson TM, Dawson VL et al (2012) Neurodegenerative phenotypes in an A53T alpha-synuclein transgenic mouse model are independent of LRRK2. Hum Mol Genet 21:2420\u20132431. \n                    https:\/\/doi.org\/10.1093\/hmg\/dds057","journal-title":"Hum Mol Genet"},{"key":"538_CR8","doi-asserted-by":"publisher","first-page":"e1005944","DOI":"10.1371\/journal.pgen.1005944","volume":"12","author":"MY Davis","year":"2016","unstructured":"Davis MY, Trinh K, Thomas RE, Yu S, Germanos AA, Whitley BN, Sardi SP, Montine TJ, Pallanck LJ (2016) Glucocerebrosidase deficiency in Drosophila results in alpha-Synuclein-independent protein aggregation and neurodegeneration. PLoS Genet 12:e1005944. \n                    https:\/\/doi.org\/10.1371\/journal.pgen.1005944","journal-title":"PLoS Genet"},{"key":"538_CR9","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1002\/mds.22538","volume":"24","author":"J DePaolo","year":"2009","unstructured":"DePaolo J, Goker-Alpan O, Samaddar T, Lopez G, Sidransky E (2009) The association between mutations in the lysosomal protein glucocerebrosidase and parkinsonism. Mov Disord 24:1571\u20131578. \n                    https:\/\/doi.org\/10.1002\/mds.22538","journal-title":"Mov Disord"},{"key":"538_CR10","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.1093\/brain\/awu291","volume":"137","author":"I Fishbein","year":"2014","unstructured":"Fishbein I, Kuo YM, Giasson BI, Nussbaum RL (2014) Augmentation of phenotype in a transgenic Parkinson mouse heterozygous for a Gaucher mutation. Brain 137:3235\u20133247. \n                    https:\/\/doi.org\/10.1093\/brain\/awu291","journal-title":"Brain"},{"key":"538_CR11","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/ana.23614","volume":"72","author":"ME Gegg","year":"2012","unstructured":"Gegg ME, Burke D, Heales SJ, Cooper JM, Hardy J, Wood NW, Schapira AH (2012) Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains. Ann Neurol 72:455\u2013463. \n                    https:\/\/doi.org\/10.1002\/ana.23614","journal-title":"Ann Neurol"},{"key":"538_CR12","doi-asserted-by":"publisher","unstructured":"Gegg ME, Schapira AHV (2018) The role of glucocerebrosidase in Parkinson disease pathogenesis. FEBS J. \n                    https:\/\/doi.org\/10.1111\/febs.14393","DOI":"10.1111\/febs.14393"},{"key":"538_CR13","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/35081564","volume":"2","author":"M Goedert","year":"2001","unstructured":"Goedert M (2001) Alpha-synuclein and neurodegenerative diseases. Nat Rev Neurosci 2:492\u2013501. \n                    https:\/\/doi.org\/10.1038\/35081564","journal-title":"Nat Rev Neurosci"},{"key":"538_CR14","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nrn3689","volume":"15","author":"C Hetz","year":"2014","unstructured":"Hetz C, Mollereau B (2014) Disturbance of endoplasmic reticulum proteostasis in neurodegenerative diseases. Nat Rev Neurosci 15:233\u2013249. \n                    https:\/\/doi.org\/10.1038\/nrn3689","journal-title":"Nat Rev Neurosci"},{"key":"538_CR15","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/nrneurol.2017.99","volume":"13","author":"C Hetz","year":"2017","unstructured":"Hetz C, Saxena S (2017) ER stress and the unfolded protein response in neurodegeneration. Nat Rev Neurol 13:477\u2013491. \n                    https:\/\/doi.org\/10.1038\/nrneurol.2017.99","journal-title":"Nat Rev Neurol"},{"key":"538_CR16","doi-asserted-by":"publisher","first-page":"30891","DOI":"10.1038\/srep30891","volume":"6","author":"C Kim","year":"2016","unstructured":"Kim C, Lv G, Lee JS, Jung BC, Masuda-Suzukake M, Hong CS, Valera E, Lee HJ, Paik SR, Hasegawa M et al (2016) Exposure to bacterial endotoxin generates a distinct strain of alpha-synuclein fibril. Sci Rep 6:30891. \n                    https:\/\/doi.org\/10.1038\/srep30891","journal-title":"Sci Rep"},{"key":"538_CR17","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1073\/pnas.1700465115","volume":"115","author":"S Kim","year":"2018","unstructured":"Kim S, Yun SP, Lee S, Umanah GE, Bandaru VVR, Yin X, Rhee P, Karuppagounder SS, Kwon SH, Lee H et al (2018) GBA1 deficiency negatively affects physiological alpha-synuclein tetramers and related multimers. Proc Natl Acad Sci U S A 115:798\u2013803. \n                    https:\/\/doi.org\/10.1073\/pnas.1700465115","journal-title":"Proc Natl Acad Sci U S A"},{"key":"538_CR18","doi-asserted-by":"publisher","first-page":"12972","DOI":"10.1074\/jbc.M802790200","volume":"284","author":"K Kitatani","year":"2009","unstructured":"Kitatani K, Sheldon K, Rajagopalan V, Anelli V, Jenkins RW, Sun Y, Grabowski GA, Obeid LM, Hannun YA (2009) Involvement of acid beta-glucosidase 1 in the salvage pathway of ceramide formation. J Biol Chem 284:12972\u201312978. \n                    https:\/\/doi.org\/10.1074\/jbc.M802790200","journal-title":"J Biol Chem"},{"key":"538_CR19","doi-asserted-by":"publisher","first-page":"8968","DOI":"10.1073\/pnas.132197599","volume":"99","author":"MK Lee","year":"2002","unstructured":"Lee MK, Stirling W, Xu Y, Xu X, Qui D, Mandir AS, Dawson TM, Copeland NG, Jenkins NA, Price DL (2002) Human alpha-synuclein-harboring familial Parkinson's disease-linked ala-53 --> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice. Proc Natl Acad Sci U S A 99:8968\u20138973. \n                    https:\/\/doi.org\/10.1073\/pnas.132197599","journal-title":"Proc Natl Acad Sci U S A"},{"key":"538_CR20","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L, Bennett ML, Munch AE, Chung WS, Peterson TC et al (2017) Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541:481\u2013487. \n                    https:\/\/doi.org\/10.1038\/nature21029","journal-title":"Nature"},{"key":"538_CR21","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.ymgme.2013.04.012","volume":"109","author":"G Lopez","year":"2013","unstructured":"Lopez G, Sidransky E (2013) Predicting parkinsonism: new opportunities from Gaucher disease. Mol Genet Metab 109:235\u2013236. \n                    https:\/\/doi.org\/10.1016\/j.ymgme.2013.04.012","journal-title":"Mol Genet Metab"},{"key":"538_CR22","doi-asserted-by":"publisher","first-page":"21665","DOI":"10.1073\/pnas.1014376107","volume":"107","author":"J Lu","year":"2010","unstructured":"Lu J, Chiang J, Iyer RR, Thompson E, Kaneski CR, Xu DS, Yang C, Chen M, Hodes RJ, Lonser RR et al (2010) Decreased glucocerebrosidase activity in Gaucher disease parallels quantitative enzyme loss due to abnormal interaction with TCP1 and c-Cbl. Proc Natl Acad Sci U S A 107:21665\u201321670. \n                    https:\/\/doi.org\/10.1073\/pnas.1014376107","journal-title":"Proc Natl Acad Sci U S A"},{"key":"538_CR23","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1126\/science.1227157","volume":"338","author":"KC Luk","year":"2012","unstructured":"Luk KC, Kehm V, Carroll J, Zhang B, O'Brien P, Trojanowski JQ, Lee VM (2012) Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 338:949\u2013953. \n                    https:\/\/doi.org\/10.1126\/science.1227157","journal-title":"Science"},{"key":"538_CR24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1523\/JNEUROSCI.4308-05.2006","volume":"26","author":"LJ Martin","year":"2006","unstructured":"Martin LJ, Pan Y, Price AC, Sterling W, Copeland NG, Jenkins NA, Price DL, Lee MK (2006) Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death. J Neurosci 26:41\u201350. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.4308-05.2006","journal-title":"J Neurosci"},{"key":"538_CR25","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1001\/archneurol.2007.68","volume":"65","author":"IF Mata","year":"2008","unstructured":"Mata IF, Samii A, Schneer SH, Roberts JW, Griffith A, Leis BC, Schellenberg GD, Sidransky E, Bird TD, Leverenz JB et al (2008) Glucocerebrosidase gene mutations: a risk factor for Lewy body disorders. Arch Neurol 65:379\u2013382. \n                    https:\/\/doi.org\/10.1001\/archneurol.2007.68","journal-title":"Arch Neurol"},{"key":"538_CR26","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0165-0270(96)02211-X","volume":"73","author":"K Matsuura","year":"1997","unstructured":"Matsuura K, Kabuto H, Makino H, Ogawa N (1997) Pole test is a useful method for evaluating the mouse movement disorder caused by striatal dopamine depletion. J Neurosci Methods 73:45\u201348","journal-title":"J Neurosci Methods"},{"key":"538_CR27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cell.2011.06.001","volume":"146","author":"JR Mazzulli","year":"2011","unstructured":"Mazzulli JR, Xu YH, Sun Y, Knight AL, McLean PJ, Caldwell GA, Sidransky E, Grabowski GA, Krainc D (2011) Gaucher disease glucocerebrosidase and alpha-synuclein form a bidirectional pathogenic loop in synucleinopathies. Cell 146:37\u201352. \n                    https:\/\/doi.org\/10.1016\/j.cell.2011.06.001","journal-title":"Cell"},{"key":"538_CR28","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.brainres.2016.04.042","volume":"1648","author":"G Mercado","year":"2016","unstructured":"Mercado G, Castillo V, Soto P, Sidhu A (2016) ER stress and Parkinson's disease: pathological inputs that converge into the secretory pathway. Brain Res 1648:626\u2013632. \n                    https:\/\/doi.org\/10.1016\/j.brainres.2016.04.042","journal-title":"Brain Res"},{"issue":"Suppl 1","key":"538_CR29","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/jnc.13385","volume":"139","author":"A Migdalska-Richards","year":"2016","unstructured":"Migdalska-Richards A, Schapira AH (2016) The relationship between glucocerebrosidase mutations and Parkinson disease. J Neurochem 139(Suppl 1):77\u201390. \n                    https:\/\/doi.org\/10.1111\/jnc.13385","journal-title":"J Neurochem"},{"key":"538_CR30","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1093\/brain\/awx221","volume":"140","author":"A Migdalska-Richards","year":"2017","unstructured":"Migdalska-Richards A, Wegrzynowicz M, Rusconi R, Deangeli G, Di Monte DA, Spillantini MG, Schapira AHV (2017) The L444P Gba1 mutation enhances alpha-synuclein induced loss of nigral dopaminergic neurons in mice. Brain 140:2706\u20132721. \n                    https:\/\/doi.org\/10.1093\/brain\/awx221","journal-title":"Brain"},{"key":"538_CR31","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1093\/brain\/awt367","volume":"137","author":"KE Murphy","year":"2014","unstructured":"Murphy KE, Gysbers AM, Abbott SK, Tayebi N, Kim WS, Sidransky E, Cooper A, Garner B, Halliday GM (2014) Reduced glucocerebrosidase is associated with increased alpha-synuclein in sporadic Parkinson's disease. Brain 137:834\u2013848. \n                    https:\/\/doi.org\/10.1093\/brain\/awt367","journal-title":"Brain"},{"key":"538_CR32","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1001\/jamaneurol.2013.1925","volume":"70","author":"MA Nalls","year":"2013","unstructured":"Nalls MA, Duran R, Lopez G, Kurzawa-Akanbi M, McKeith IG, Chinnery PF, Morris CM, Theuns J, Crosiers D, Cras P et al (2013) A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies. JAMA Neurol 70:727\u2013735. \n                    https:\/\/doi.org\/10.1001\/jamaneurol.2013.1925","journal-title":"JAMA Neurol"},{"key":"538_CR33","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1056\/NEJM2003ra020003","volume":"348","author":"RL Nussbaum","year":"2003","unstructured":"Nussbaum RL (2003) Alzheimer's disease and Parkinson's disease (vol 348, pg 1356, 2003). New Engl J Med 348:2588\u20132588","journal-title":"New Engl J Med"},{"key":"538_CR34","doi-asserted-by":"publisher","unstructured":"Pitcairn C, Wani WY, Mazzulli JR (2018) Dysregulation of the autophagic-lysosomal pathway in Gaucher and Parkinson's disease. Neurobiol Dis. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2018.03.008","DOI":"10.1016\/j.nbd.2018.03.008"},{"key":"538_CR35","doi-asserted-by":"publisher","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J, Schrag AE, Lang AE (2017) Parkinson disease. Nat Rev Dis Primers 3:17013. \n                    https:\/\/doi.org\/10.1038\/nrdp.2017.13","journal-title":"Nat Rev Dis Primers"},{"key":"538_CR36","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/acn3.177","volume":"2","author":"EM Rocha","year":"2015","unstructured":"Rocha EM, Smith GA, Park E, Cao H, Brown E, Hallett P, Isacson O (2015) Progressive decline of glucocerebrosidase in aging and Parkinson's disease. Ann Clin Transl Neurol 2:433\u2013438. \n                    https:\/\/doi.org\/10.1002\/acn3.177","journal-title":"Ann Clin Transl Neurol"},{"key":"538_CR37","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1093\/hmg\/ddw124","volume":"25","author":"E Rockenstein","year":"2016","unstructured":"Rockenstein E, Clarke J, Viel C, Panarello N, Treleaven CM, Kim C, Spencer B, Adame A, Park H, Dodge JC et al (2016) Glucocerebrosidase modulates cognitive and motor activities in murine models of Parkinson's disease. Hum Mol Genet 25:2645\u20132660. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddw124","journal-title":"Hum Mol Genet"},{"key":"538_CR38","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1038\/nm.4397","volume":"23","author":"MW Salter","year":"2017","unstructured":"Salter MW, Stevens B (2017) Microglia emerge as central players in brain disease. Nat Med 23:1018\u20131027. \n                    https:\/\/doi.org\/10.1038\/nm.4397","journal-title":"Nat Med"},{"key":"538_CR39","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1172\/JCI29178","volume":"116","author":"JM Savitt","year":"2006","unstructured":"Savitt JM, Dawson VL, Dawson TM (2006) Diagnosis and treatment of Parkinson disease: molecules to medicine. J Clin Invest 116:1744\u20131754. \n                    https:\/\/doi.org\/10.1172\/JCI29178","journal-title":"J Clin Invest"},{"key":"538_CR40","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.mcn.2015.03.013","volume":"66","author":"AH Schapira","year":"2015","unstructured":"Schapira AH (2015) Glucocerebrosidase and Parkinson disease: recent advances. Mol Cell Neurosci 66:37\u201342. \n                    https:\/\/doi.org\/10.1016\/j.mcn.2015.03.013","journal-title":"Mol Cell Neurosci"},{"key":"538_CR41","doi-asserted-by":"publisher","first-page":"4028","DOI":"10.1038\/ncomms5028","volume":"5","author":"DC Schondorf","year":"2014","unstructured":"Schondorf DC, Aureli M, McAllister FE, Hindley CJ, Mayer F, Schmid B, Sardi SP, Valsecchi M, Hoffmann S, Schwarz LK et al (2014) iPSC-derived neurons from GBA1-associated Parkinson's disease patients show autophagic defects and impaired calcium homeostasis. Nat Commun 5:4028. \n                    https:\/\/doi.org\/10.1038\/ncomms5028","journal-title":"Nat Commun"},{"key":"538_CR42","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/S1474-4422(12)70190-4","volume":"11","author":"E Sidransky","year":"2012","unstructured":"Sidransky E, Lopez G (2012) The link between the GBA gene and parkinsonism. Lancet Neurol 11:986\u2013998. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(12)70190-4","journal-title":"Lancet Neurol"},{"key":"538_CR43","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M (1997) Alpha-synuclein in Lewy bodies. Nature 388:839\u2013840. \n                    https:\/\/doi.org\/10.1038\/42166","journal-title":"Nature"},{"key":"538_CR44","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ymgme.2017.11.001","volume":"122","author":"N Tayebi","year":"2017","unstructured":"Tayebi N, Parisiadou L, Berhe B, Gonzalez AN, Serra-Vinardell J, Tamargo RJ, Maniwang E, Sorrentino Z, Fujiwara H, Grey RJ et al (2017) Glucocerebrosidase haploinsufficiency in A53T alpha-synuclein mice impacts disease onset and course. Mol Genet Metab 122:198\u2013208. \n                    https:\/\/doi.org\/10.1016\/j.ymgme.2017.11.001","journal-title":"Mol Genet Metab"},{"key":"538_CR45","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1016\/S0002-9440(10)63566-3","volume":"163","author":"YH Xu","year":"2003","unstructured":"Xu YH, Quinn B, Witte D, Grabowski GA (2003) Viable mouse models of acid beta-glucosidase deficiency: the defect in Gaucher disease. Am J Pathol 163:2093\u20132101","journal-title":"Am J Pathol"},{"key":"538_CR46","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1073\/pnas.1424288112","volume":"112","author":"C Yang","year":"2015","unstructured":"Yang C, Wang H, Zhu D, Hong CS, Dmitriev P, Zhang C, Li Y, Ikejiri B, Brady RO, Zhuang Z (2015) Mutant glucocerebrosidase in Gaucher disease recruits Hsp27 to the Hsp90 chaperone complex for proteasomal degradation. Proc Natl Acad Sci U S A 112:1137\u20131142. \n                    https:\/\/doi.org\/10.1073\/pnas.1424288112","journal-title":"Proc Natl Acad Sci U S A"},{"key":"538_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-017-0233-5","volume":"13","author":"SP Yun","year":"2018","unstructured":"Yun SP, Kim D, Kim S, Kim S, Karuppagounder SS, Kwon SH, Lee S, Kam TI, Lee S, Ham S et al (2018) Alpha-Synuclein accumulation and GBA deficiency due to L444P GBA mutation contributes to MPTP-induced parkinsonism. Mol Neurodegener 13:1. \n                    https:\/\/doi.org\/10.1186\/s13024-017-0233-5","journal-title":"Mol Neurodegener"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-018-0538-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40478-018-0538-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-018-0538-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T11:04:09Z","timestamp":1589540649000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-018-0538-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,27]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["538"],"URL":"https:\/\/doi.org\/10.1186\/s40478-018-0538-9","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.733126583.793548464","asserted-by":"object"}]},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,27]]},"assertion":[{"value":"14 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All experimental procedures were in accordance with the guidelines of Laboratory Animal Manual of National Institute of Health Guide for the Care and Use of Animals. All animal experiments were complied with the current laws of the United States. They were approved by the Johns Hopkins Medical Institute Animal Care and Use Committee.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"32"}}